Novartis is set to invest $23 billion in US-based manufacturing and research and development (R&D) over the next five years, ...

The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...

Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2025 results on April 29, 2025. The Zacks ...

Novartis is one of the world's top pharmaceutical companies, and along with neighbours Roche, the mainstay of Switzerland's centuries-long contribution to new medicines. Headquartered in Basel ...

At the same time, drugmakers have come to rely on the U.S. market for the bulk of their revenue. In 2022, the U.S. accounted ...

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of ...

Alembic Pharmaceuticals announced that it has received final approval from the U.S. Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Carbamazepine Tablets USP, ...

Hikma Pharmaceuticals (OTCPK:HKMPF) announced on Thursday that it has acquired the FDA-approved Abbreviated New Drug ...

The surge in layoffs comes amidst concerns over the impact of President Donald Trump’s tariffs on the nation’s product ...

Mid-sized Indian pharma firms revamp strategies amid US tariff concerns, focusing on NCDs, API manufacturing, emerging ...

it’s been said that the French government also contributed to the acquisition by encouraging Sanofi-Synthélabo to increase its bid after hearing that Swiss pharmaceutical company Novartis was ...

Sustainabilitycategory· April 15, 2025 European pharma companies issue demands to stay in EU ahead of expected US tariffs Nearly three dozen global pharmaceutical companies, in a letter to the ...